Detail View

T 보조세포 유래의 세포외 소포체로 활성화된 세포독성 T 세포를 유효성분으로 포함하는 암 질환의 예방 또는 치료용 조성물
Citations

WEB OF SCIENCE

Citations

SCOPUS

Metadata Downloads

Title
T 보조세포 유래의 세포외 소포체로 활성화된 세포독성 T 세포를 유효성분으로 포함하는 암 질환의 예방 또는 치료용 조성물
Alternative Title
COMPOSITION, FOR PREVENTION OR TREATMENT OF CANCER DISEASE, COMPRISING CYTOTOXIC T CELLS ACTIVATED BY T HELPER CELL-DERIVED EXTRACELLULAR VESICLES AS ACTIVE INGREDIENT
Country
US
Application Date
2022-04-06
Application No.
17-766745
Registration Date
2025-10-28
Publication No.
12,453,775
Assignee
(재)대구경북과학기술원(50/0),경북대학교 산학협력단(50/0),트로이와이(0/100)
URI
https://scholar.dgist.ac.kr/handle/20.500.11750/59162 17-766745
Abstract
The present invention relates to a composition, for prevention or treatment of cancer diseases, comprising CD8+ T cells activated by CD4+ T cell-derived extracellular vesicles as an active ingredient. It was found that the secretion of extracellular vesicles from cytokine-activated CD4+ T cells increases and the extracellular vesicles enhance proliferation and activity of CD8+ T cells to induce the death of cancer cells, thereby augmenting an anticancer effect. Thus, the present invention provides the CD8+ T cells activated by CD4+ T cell-derived extracellular vesicles as a pharmaceutical agent or an immunotherapeutic agent for cancer diseases, and a method for activating CD8+ T cells by using CD4+ T cell-derived extracellular vesicles to prepare CD8+ T cells showing excellent anticancer activity as described above.
Show Full Item Record

File Downloads

  • There are no files associated with this item.

공유

qrcode
공유하기

Related Researcher

예경무
Yea, Kyungmoo예경무

Department of New Biology

read more

Total Views & Downloads